MediWound (MDWD) News Today $16.35 -0.24 (-1.45%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$16.36 +0.01 (+0.06%) As of 04/15/2025 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period MediWound (NASDAQ:MDWD) Stock Passes Below 200 Day Moving Average - Here's WhyMediWound (NASDAQ:MDWD) Stock Passes Below Two Hundred Day Moving Average - Time to Sell?April 11, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Share Price Passes Below 200-Day Moving Average - Should You Sell?April 9, 2025 | americanbankingnews.comHC Wainwright Has Bearish Estimate for MediWound Q1 EarningsMediWound Ltd. (NASDAQ:MDWD - Free Report) - Research analysts at HC Wainwright lowered their Q1 2025 earnings per share estimates for shares of MediWound in a research report issued to clients and investors on Thursday, March 20th. HC Wainwright analyst S. Ramakanth now expects that the biopharmMarch 24, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Upgraded to Sell at StockNews.comStockNews.com upgraded MediWound to a "sell" rating in a research report on Friday.March 22, 2025 | marketbeat.comAnalysts Offer Predictions for MediWound FY2029 EarningsMediWound Ltd. (NASDAQ:MDWD - Free Report) - Analysts at HC Wainwright issued their FY2029 earnings estimates for MediWound in a note issued to investors on Thursday, March 20th. HC Wainwright analyst S. Ramakanth forecasts that the biopharmaceutical company will earn $2.45 per share for the yearMarch 22, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Earns "Buy" Rating from HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $25.00 price objective on shares of MediWound in a report on Thursday.March 21, 2025 | marketbeat.comMediWound reports Q4 EPS (36c), consensus (61c)March 20, 2025 | markets.businessinsider.comMediWound files $125M mixed securities shelfMarch 20, 2025 | markets.businessinsider.comLoss-Making MediWound Ltd. (NASDAQ:MDWD) Expected To Breakeven In The Medium-TermMarch 20, 2025 | finance.yahoo.comMediWound (NASDAQ:MDWD) Posts Earnings Results, Beats Estimates By $0.25 EPSMediWound (NASDAQ:MDWD - Get Free Report) released its earnings results on Wednesday. The biopharmaceutical company reported ($0.36) EPS for the quarter, beating the consensus estimate of ($0.61) by $0.25. MediWound had a negative net margin of 142.29% and a negative return on equity of 82.17%. During the same period last year, the company posted ($0.19) EPS.March 20, 2025 | marketbeat.comMediWound Ltd. (MDWD) Q4 2024 Earnings Call TranscriptMarch 20, 2025 | seekingalpha.comMediWound Reports 2024 Financials and Strategic AdvancesMarch 19, 2025 | tipranks.comMediWound shares rise as Q4 loss is narrower than expectedMarch 19, 2025 | investing.comMediWound Reports 2024 Financial Results and Strategic AdvancesMarch 19, 2025 | tipranks.comMediWound Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate UpdateMarch 19, 2025 | globenewswire.comMediWound Q4 2024 Earnings PreviewMarch 18, 2025 | msn.comMediwound (MDWD) Receives a New Rating from Craig-HallumMarch 17, 2025 | markets.businessinsider.comMediWound (MDWD) Projected to Post Earnings on WednesdayMediWound (NASDAQ:MDWD) will be releasing earnings before the market opens on Wednesday, March 19, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=671988)March 12, 2025 | marketbeat.comEssex Investment Management Co. LLC Acquires 35,012 Shares of MediWound Ltd. (NASDAQ:MDWD)Essex Investment Management Co. LLC raised its holdings in MediWound Ltd. (NASDAQ:MDWD - Free Report) by 30.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 148,949 shares of the biopharmaceutical company's stock aftMarch 10, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Stock Passes Below 200 Day Moving Average - Time to Sell?MediWound (NASDAQ:MDWD) Stock Crosses Below 200-Day Moving Average - What's Next?March 8, 2025 | marketbeat.comMediWound to Report Fourth Quarter and Full Year 2024 Financial ResultsMarch 3, 2025 | globenewswire.comMediWound (NASDAQ:MDWD) Now Covered by Analysts at Craig HallumCraig Hallum started coverage on shares of MediWound in a research report on Friday. They issued a "buy" rating and a $39.00 target price on the stock.March 1, 2025 | marketbeat.comMediWound Ltd. (NASDAQ:MDWD) Stock Position Boosted by Yelin Lapidot Holdings Management Ltd.Yelin Lapidot Holdings Management Ltd. grew its stake in shares of MediWound Ltd. (NASDAQ:MDWD - Free Report) by 13.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 851,361 shares of the biopharmaceuticaMarch 1, 2025 | marketbeat.comCraig-Hallum starts MediWound with Buy on EscharEx potentialMarch 1, 2025 | markets.businessinsider.comMediWound initiated with a Buy at Craig-HallumMarch 1, 2025 | markets.businessinsider.comCraig-Hallum Initiates Coverage of MediWound (MDWD) with Buy RecommendationMarch 1, 2025 | msn.comMediWound announces Phase III CIDS publication on NexoBridFebruary 25, 2025 | markets.businessinsider.comMediWound Announces Phase III CIDS Publication on NexoBrid® for Pediatric Burn CareFebruary 25, 2025 | globenewswire.comMediWound to Present at the 45th Annual TD Cowen Health Care ConferenceFebruary 24, 2025 | globenewswire.comMediWound (NASDAQ:MDWD) Stock Price Crosses Below Two Hundred Day Moving Average - Time to Sell?MediWound (NASDAQ:MDWD) Stock Passes Below 200-Day Moving Average - Should You Sell?February 22, 2025 | marketbeat.comMediWound Ltd.: MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx for Treatment of Venous Leg UlcersFebruary 12, 2025 | finanznachrichten.deMediWound begins pivotal Phase III trial for wound therapyFebruary 12, 2025 | msn.comMediWound stock climbs 4% on Phase 3 study initiationFebruary 12, 2025 | msn.comMediWound to launch Phase III trial for venous leg ulcersFebruary 12, 2025 | reuters.comMediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg UlcersFebruary 12, 2025 | globenewswire.comMediWound to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceFebruary 4, 2025 | finance.yahoo.comJPMorgan Chase & Co. Sells 75,360 Shares of MediWound Ltd. (NASDAQ:MDWD)JPMorgan Chase & Co. decreased its position in MediWound Ltd. (NASDAQ:MDWD - Free Report) by 95.7% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 3,401 shares of the biopharmaceuticalFebruary 4, 2025 | marketbeat.comMediWound Ltd.'s (NASDAQ:MDWD) high institutional ownership speaks for itself as stock continues to impress, up 15% over last weekJanuary 29, 2025 | finance.yahoo.comBuy Rating for Mediwound Driven by EscharEx’s Market Potential and Disruptive Role in Chronic Wound CareJanuary 11, 2025 | markets.businessinsider.comMediwound (MDWD) Receives a Buy from TD CowenJanuary 10, 2025 | markets.businessinsider.comBuy Rating for Mediwound Driven by EscharEx’s Promising Market Potential and Revenue GrowthJanuary 10, 2025 | markets.businessinsider.comState Street Corp Raises Holdings in MediWound Ltd. (NASDAQ:MDWD)State Street Corp boosted its stake in MediWound Ltd. (NASDAQ:MDWD - Free Report) by 219.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 66,258 shares of the biopharmaceutical company's stock after purchasing an addiJanuary 3, 2025 | marketbeat.comMediWound (NASDAQ:MDWD) Share Price Passes Below 50-Day Moving Average - Should You Sell?MediWound (NASDAQ:MDWD) Stock Price Passes Below Fifty Day Moving Average - Should You Sell?December 28, 2024 | marketbeat.comWe're Keeping An Eye On MediWound's (NASDAQ:MDWD) Cash Burn RateDecember 24, 2024 | finance.yahoo.comMediWound Approves 2024 Share Incentive Plan to Boost Employee EngagementDecember 19, 2024 | tipranks.comMediWound to host virtual KOL event to discuss EscharEx Phase III VALUE studyDecember 18, 2024 | markets.businessinsider.comMediWound Executives Acquire 18,462 Shares, Signaling Confidence in Company’s FutureDecember 17, 2024 | markets.businessinsider.comStrategic Growth and Market Potential Drive Buy Rating for MediWound Despite Revenue DeclineDecember 6, 2024 | markets.businessinsider.comBrokers Offer Predictions for MediWound FY2024 EarningsMediWound Ltd. (NASDAQ:MDWD - Free Report) - Equities research analysts at HC Wainwright decreased their FY2024 EPS estimates for MediWound in a research note issued on Wednesday, November 27th. HC Wainwright analyst S. Ramakanth now anticipates that the biopharmaceutical company will post earninDecember 2, 2024 | marketbeat.comMediWound (NASDAQ:MDWD) Stock, Option ChainNovember 28, 2024 | benzinga.com Remove Ads Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address MDWD Media Mentions By Week MDWD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDWD News Sentiment▼0.870.78▲Average Medical News Sentiment MDWD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDWD Articles This Week▼32▲MDWD Articles Average Week Remove Ads Get MediWound News Delivered to You Automatically Sign up to receive the latest news and ratings for MDWD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Nuvation Bio News Cronos Group News Pharvaris News Evolus News Xeris Biopharma News LENZ Therapeutics News Immunome News Rocket Pharmaceuticals News Xencor News Arbutus Biopharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDWD) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredCatastrophicThe losses are catastrophic... $760 billion wiped off the Magnificent 7, in a single day.InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MediWound Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share MediWound With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDWD Stock Free MDWD Stock Alerts